More of key HIV drug to be given
AUTHORITIES are continuing to escalate their efforts to contain HIV/Aids in the country. In this regard, they say 43 000 citizens will... To access this content, please...
Search fresh public links, source activity, and post angles for Hiv Drugs.
Fresh curated links around HIV drugs are collected here so marketers can spot useful updates and turn timely ideas into posts faster.
Recent items include:
Recent curated links from global sources. Generate one free draft from any story, then use SocialBu to schedule and refine your content calendar.
AUTHORITIES are continuing to escalate their efforts to contain HIV/Aids in the country. In this regard, they say 43 000 citizens will... To access this content, please...
AUTHORITIES are continuing to escalate their efforts to contain HIV/Aids in the country. In this regard, they say 43 000 citizens will... To access this content, please...
Nigeria is transitioning from daily HIV treatment to a biannual Lenacapavir injection, aiming to improve adherence and reduce stigma by transforming a daily regimen into a discreet...
[SAnews.gov.za] The launch of Lenacapavir - a groundbreaking HIV drug - will be held on June 5 in Mpumalanga.
Merck’s HIV drug Idvynso could become a drug choice for patients who need to switch from Gilead Sciences’ Biktarvy for safety or tolerability reasons. The Merck combination drug pa...
Advances in HIV treatment have transformed what was once a fatal diagnosis into a manageable chronic condition. Today, children living with HIV are surviving—and increasingly thr...
Zimbabwe’s Human Immunodeficiency Virus (HIV) epidemic has been among the most severe globally, shaped by decades of social, economic and structural pressures. At the turn of the 2...
[Daily Trust] The fight against HIV/AIDS in Nigeria got a boost with the introduction of twice-yearly injectable Lenacapavir (LEN) in eight states. The rollout, which will begin in...
With rollout underway in nine countries, early data indicate strong uptake among priority populations.
The number of new HIV cases has been falling over the years, said the Communicable Diseases Agency, although there was a slight increase in 2025.
Leronlimab is an antiviral HIV drug that targets and blocks the CCR5 receptor, thus blocking HIV’s ability to invade immune cells. Most macaques that produced sufficient number of...
Lenacapavir, which protects people from H.I.V. infection with twice-yearly shots, is arriving in a country where the health system has been hollowed out by American aid cuts.
[Health-e] South Africans are being told that providing a new HIV prevention tool (lenacapavir) to just about 456,000 people is a victory. It is not. In a country that still record...
The Anambra State Ministry of Health over the weekend, flagged off the roll-out of Lenacapavir (LEN PrEP), a long-acting injectable for the prevention of the Human Immunodeficiency...
For individuals living with HIV, the advent of antiretroviral therapy (ART) has transformed what was once a fatal diagnosis into a manageable chronic condition. While ART effective...
[AIM] Maputo -- The Mozambican health authorities on Wednesday launched a long-acting injectable PrEP against HIV, which is capable of reducing the risk of infections by more than...
[spotlight] Along dusty roads in northern KwaZulu-Natal, Spotlight speaks to youth leaders, community mentors and leading scientists who are collaborating to bring a groundbreaking...
Gilead’s Tomas Cihlar and his team of researchers have spent decades studying HIV—and their latest innovation could be a game changer for prevention.
For decades, the problem was the cells themselves. Human CD4+ T cells, the immune sentinels that HIV dismantles so methodically, turned out to be almost impossibly difficult to inf...
Three people were able to suppress the virus for months without their usual treatment regimen.
As part of a years-long effort by PrEP4ALL and other HIV groups to get Gilead Sciences, a pharmaceutical company, to lower the cost of Truvada, which is used in pre-exposure prophy...
Gilead's lenacapavir could transform the fight against HIV — but only if millions more patients can get it.
[allAfrica] Pharmaceutical company Gilead Sciences has come under mounting pressure after refusing to sell its breakthrough HIV prevention drug, lenacapavir, directly to Médecins S...
Use SocialBu to discover ideas, generate post drafts, and schedule them across your social channels.